Long-term follow-up of Japanese encephalitis chimeric virus vaccine: Immune responses in children

Long-term follow-up of Japanese encephalitis chimeric virus vaccine: Immune responses in children

© 2016 Elsevier Ltd Background A single dose of live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) was shown to be immunogenic and well tolerated when given either as a booster to formalin-inactivated Japanese encephalitis (JE)-vaccine (mouse brain-derived vaccine [MBDV])-primed 2–...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kulkanya Chokephaibulkit, Chukiat Sirivichayakul, Usa Thisyakorn, Chitsanu Pancharoen, Mark Boaz, Alain Bouckenooghe, Emmanuel Feroldi
Other Authors:	Mahidol University
Format:	Article
Published:	2018
Subjects:	Biochemistry, Genetics and Molecular Biology Immunology and Microbiology Medicine
Online Access:	https://repository.li.mahidol.ac.th/handle/123456789/42414
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	Mahidol University

Similar Items

Safety and immunogenicity of a single administration of live-attenuated japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: Multicenter randomized controlled trial
by: Kulkanya Chokephaibulkit, et al.
Published: (2018)

Safety and immunogenicity of a live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV®) in children
by: K. Chokephaibulkit, et al.
Published: (2018)

Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from South-East Asia and India
by: Matthew Bonaparte, et al.
Published: (2018)

Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from South-East Asia and India
by: Bonaparte, Matthew, et al.
Published: (2015)

Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children
by: Pakpoom Janewongwirot, et al.
Published: (2018)

Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine: Randomized, double-blind, 5-year phase II study in healthy adults
by: Peter E. Nasveld, et al.
Published: (2018)

A 3-year follow-up of antibody response in HIV-infected children with immune recovery vaccinated with inactivated Japanese encephalitis vaccine
by: Puthanakit T., et al.
Published: (2014)

A 3-year follow-up of antibody response in HIV-infected children with immune recovery vaccinated with inactivated Japanese encephalitis vaccine
by: Thanyawee Puthanakit, et al.
Published: (2018)

A 3-year follow-up of antibody response in HIV-infected children with immune recovery vaccinated with inactivated Japanese encephalitis vaccine
by: Thanyawee Puthanakit, et al.
Published: (2018)

Japanese encephalitis: Update on vaccines and vaccine recommendations
by: Wilder-Smith, A., et al.
Published: (2016)

Immunogenicity and safety of two-visit, intradermal pre-exposure rabies prophylaxis simultaneously administrated with chimeric live-attenuated Japanese encephalitis vaccine in children living in rabies and Japanese encephalitis endemic country
by: Piyada Angsuwatcharakon, et al.
Published: (2020)

Persistence of hepatitis B immune memory until 9–10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP∼T vaccination at 2, 4 and 6 months
by: Pope Kosalaraksa, et al.
Published: (2019)

Japanese encephalitis vaccine development (Yokohama, 2006)
by: No information provided
Published: (2012)

Production of single-round infectious chimeric flaviviruses with DNA-based Japanese encephalitis virus replicon
by: Ryosuke Suzuki, et al.
Published: (2018)

Antibody persistence upto 5 years after primary immunization and booster with an inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
by: Weerawan Hattasingh, et al.
Published: (2022)

Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy
by: Puthanakit T., et al.
Published: (2014)

Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy
by: Thanyawee Puthanakit, et al.
Published: (2018)

Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy
by: Thanyawee Puthanakit, et al.
Published: (2018)

Japanese encephalitis: Is there a need for a novel vaccine?
by: Wilder-Smith, A., et al.
Published: (2011)

Expert opinion on vaccination of travelers against Japanese encephalitis
by: Burchard, G.D., et al.
Published: (2011)

Japanese encephalitis: Is there a need for a novel vaccine?
by: Wilder-Smith, A., et al.
Published: (2016)

A comparative study of the serological response to Japanese encephalitis vaccine in HIV-infected and uninfected Thai children
by: Kulkanya Chokephaibulkit, et al.
Published: (2018)

Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
by: Pornthep Chanthavanich, et al.
Published: (2019)

Post-licensure, phase IV, safety study of a live attenuated Japanese encephalitis recombinant vaccine in children in Thailand
by: Tawee Chotpitayasunondh, et al.
Published: (2018)

Post-licensure, phase IV, safety study of a live attenuated Japanese encephalitis recombinant vaccine in children in Thailand
by: Tawee Chotpitayasunondh, et al.
Published: (2018)

Post-licensure, phase IV, safety study of a live attenuated Japanese encephalitis recombinant vaccine in children in Thailand
by: Tawee Chotpitayasunondh, et al.
Published: (2018)

Clinical and laboratory differences between children with primary and secondary dengue infection
by: Chitsanu Pancharoen, et al.
Published: (2006)

Microencapsulation of Japanese encephalitis antigen in biodegradable polymers for vaccine delivery
by: Parichat Chomto
Published: (2013)

Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: A two-year follow-up study
by: Elina O. Erra, et al.
Published: (2018)

Japanese encephalitis
by: Arunee Sabchareon, et al.
Published: (2018)

Japanese encephalitis virus encephalitis: An overview
by: P. Thongcharoen
Published: (2018)

Japanese encephalitis virus encephalitis : an overview
by: Prasert Thongcharoen, et al.
Published: (2015)

Evaluation of chimeric DNA vaccines consisting of premembrane and envelope genes of Japanese encephalitis and dengue viruses as a strategy for reducing induction of dengue virus infection-enhancing antibody response
by: Fithriyah Sjatha, et al.
Published: (2018)

Seroepidemiological study of Japanese encephalitis virus in Chiang Mai: Immunity and susceptibility 28 years after introduction of a vaccination programme
by: Sudjaritruk T.
Published: (2023)

Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection
by: McAuley, A.J, et al.
Published: (2020)

Detection of dengue cases by serological testing in a dengue vaccine efficacy trial: Utility for efficacy evaluation and impact of future vaccine introduction
by: Eric Plennevaux, et al.
Published: (2018)

Estimates of the global burden of japanese encephalitis and the impact of vaccination from 2000-2015
by: Quan, T.M., et al.
Published: (2021)

Japanese encephalitis in Thailand
by: P. Thongcharoen
Published: (2018)

A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines
by: Elina O. Erra, et al.
Published: (2018)

A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines.
by: Elina O. Erra, et al.
Published: (2015)